Evaluation of Pomalidomide in Combination with High Dose Dexamethasone and Oral Cyclophosphamide in Patients with Relapsed and Refractory Myeloma

-
Investigator: Thomas G. Martin, MD
Sponsor: Celgene Corporation

Location(s): United States

Description

The main purpose of this study is to see whether pomalidomide can help people with myeloma. Researchers also want to find out if pomalidomide is safe and tolerable.